Status:
COMPLETED
Clinical Efficacy of Amoxicillin Given Twice or Three Times a Day Among Children With Non-severe Pneumonia
Lead Sponsor:
Federal University of Bahia
Conditions:
Community-acquired Pneumonia
Eligibility:
All Genders
2-59 years
Phase:
PHASE4
Brief Summary
The purpose of the study is to compare the clinical efficacy of amoxicillin given twice or three times a day to children with non-severe community-acquired pneumonia.
Eligibility Criteria
Inclusion
- Children aged between 2 and 59 months
- Report of respiratory complaints
- Presence of pulmonary infiltrate on chest x-ray taken on admission and read by the pediatrician on duty
Exclusion
- lower chest indrawing
- danger signs (inability to drink, convulsions, somnolence, central cyanosis, grunting in a calm child)
- diagnosed underlying chronic diseases (anatomic abnormalities of the respiratory tract, chronic pulmonary illness besides asthma, immunological defects, progressing neurological disorders, psychomotor retardation, heart disease with clinical repercussion, hemoglobinopathy, liver or kidney disease)
- severe malnutrition
- other concurrent infection
- hospitalization during the previous 7 days
- amoxicillin or similar antibiotic use during the last 48 hours
- allergy to amoxicillin
- history of aspiration
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
820 Patients enrolled
Trial Details
Trial ID
NCT01200706
Start Date
November 1 2006
End Date
May 1 2011
Last Update
July 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Professor Hosannah de Oliveira Pediatric Center
Salvador, Estado de Bahia, Brazil, 40160-170